Technology

TrilliumBiO and The LAM Foundation Partner to Advance LAM Awareness and Education

Published

2 months ago

June 29, 2026

Efforts include support for earlier diagnosis through LAMair™, TrilliumBiO’s newly developed VEGF‑D test

ROCKVILLE, Md. and CINCINNATI, June 29, 2026 /PRNewswire/ — TrilliumBiO, a leader in biomarker discovery and precision diagnostics, today announced a commitment to raising awareness of lymphangioleiomyomatosis (LAM), a rare, progressive lung disease that primarily affects women. As part of this effort, the company is proud to highlight its partnership with The LAM Foundation, the global leader in LAM research, advocacy, and patient support. Together, the organizations are working to improve understanding of LAM and strengthen the pathways that lead patients to timely diagnosis and care.

LAM is characterized by an abnormal growth of smooth muscle cells, especially in the lungs, lymphatic system, and kidneys. This growth can lead to loss of lung function, accumulation of lymph-rich fluid in the chest and abdomen, and growth of benign kidney tumors. LAM is estimated to affect 3 to 7 women per 1 million.1

“LAM patients often spend years searching for answers,” said Laura Vivian, CEO of TrilliumBiO. “By working alongside The LAM Foundation, we’re committed to increasing awareness, improving diagnostic pathways, and supporting therapeutic development to reach better outcomes for patients.”

LAM is frequently underdiagnosed or misdiagnosed due to nonspecific symptoms and overlap with common respiratory conditions. On average, women with LAM experience symptoms for 3 to 5 years and suffer more than two pneumothoraxes (which can lead to lung collapse) before receiving an accurate diagnosis.1 To support earlier identification, TrilliumBiO has developed LAMair™, a VEGF‑D (vascular endothelial growth factor D) blood test created in its multi‑accredited laboratory. LAMair™ is now available to physicians and patients nationwide.

“Our partnership with TrilliumBiO strengthens our shared mission to ensure that every person with LAM receives an accurate diagnosis and timely access to care,” said Patti Tuomey, Executive Director of The LAM Foundation. “Raising awareness among clinicians and expanding access to validated diagnostic tools are essential steps toward improving outcomes for the LAM community.”

TrilliumBiO and The LAM Foundation will continue collaborating on educational initiatives, including resources to help clinicians interpret diagnostic findings, materials that support patients after receiving test results, and programs that build broader awareness of LAM among healthcare providers. Through these joint efforts, the organizations aim to empower patients, equip providers, and accelerate scientific understanding of LAM.

Learn more about LAM, diagnostic pathways, and available testing options at The LAM Foundation: Diagnosing LAM – The LAM Foundation.

For information on assay availability or how to order LAMair™, visit LAMair™ – TrilliumBiO, contact TrilliumBiO at LAMair@trilliumbio.com, or call 1-888-261-2812.

About TrilliumBiO:
TrilliumBiO is a translational diagnostics company transforming how biomarkers are integrated into patient care. The company’s unified platform spans discovery, validation, and commercialization to deliver clinically actionable diagnostics. These solutions identify at-risk patients, monitor disease, and guide emerging therapies supporting a more personalized, data-driven model of care.

With a scalable, high-performing laboratory infrastructure, TrilliumBiO offers a portfolio of specialized, clinically tailored assays. Its partnership-driven model enables the rapid development and deployment of diagnostics in complex and underserved disease areas.

Headquartered in Maryland, just outside Washington, D.C., TrilliumBiO operates within the nation’s third-largest biopharma hub. Learn more at www.TrilliumBiO.com.

About The LAM Foundation:
The LAM Foundation provides support and education for women with LAM and their families, engages doctors and scientists to continue to learn more about the disease, and raises funds for continued research. In May 2015, the FDA approved Rapamune as the first effective treatment for LAM, based on research and patient engagement supported by The LAM Foundation.

In over 30 years, The LAM Foundation has raised over $38 million, with more than $19 million directed to research. Thanks to those grants, investigators were able to obtain an estimated $90 million in subsequent funding from other sources to advance the field of LAM research. This research effort has produced significant grant-related publications, a diagnostic biomarker that can obviate the need for lung biopsy, and a pivotal clinical trial that has identified the first treatment.

TrilliumBiO Contact:

Olivia McCann
Director, PR & Marketing Strategy
olivia.mccann@trilliumbio.com

The LAM Foundation Contact:

Patti Tuomey, Ed.D.
Executive Director
ptuomey@thelamfoundation.org

1 The LAM Foundation. Accessed January 2026. https://www.thelamfoundation.org.

Logo – https://mma.prnewswire.com/media/3001532/Untitled___March_26__2026_at_09_27_45__1_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/trilliumbio-and-the-lam-foundation-partner-to-advance-lam-awareness-and-education-302813218.html

Technology

Industry leaders to join forces to scale hydrogen mobility

Published

20 minutes ago

September 3, 2026

Volvo Group

For the first time in Europe, Germany is bringing together the full ecosystem needed to scale the deployment of hydrogen trucks by 2030, combining supportive policy frameworks, a strong OEM offering and an integrated hydrogen supply chain and infrastructure.Volvo Group, Daimler Truck, Toyota Motor Corporation, Bosch, Air Liquide, TotalEnergies, TEAL Mobility, MB Energy, and more companies accelerate the commercialization of hydrogen-powered mobility and build the ecosystem needed to scale it along the whole value chain, with vehicles, infrastructure and supply. The activities include the deployment of hydrogen refueling stations along key strategic corridors in Europe, in synchronization with the hydrogen-powered truck fleets as well as a competitive hydrogen price. This will enable customers to operate hydrogen-powered vehicles with a competitive total cost of ownership. Full details will be unveiled at a CEO-led press event during IAA Transportation in Hanover on 15 September.

GOTHENBURG, Sweden, Sept. 3, 2026 /PRNewswire/ — Leading companies from the transport, energy and industrial sectors, together with German policymakers, are collaborating to establish a benchmark for a fully integrated hydrogen mobility ecosystem for heavy-duty transport. They reflect a shared ambition to scale hydrogen with a focus on customer-oriented refueling infrastructure and competitively priced hydrogen fuel.

Delivering a comprehensive hydrogen ecosystem that complements battery-electric solutions requires coordinated development across the entire value chain with focus on commercializing competitive vehicles, deploying strategically located refueling infrastructure aligned with customer needs, and ensuring reliable access to hydrogen at viable price levels. Together, these elements can create the conditions for a competitive total cost of ownership and position hydrogen as a practical, scalable solution for zero-emission transport.

Further details will be announced on September 15 at IAA Transportation 2026.

Volvo Group, Daimler Truck, Toyota Motor Corporation, Bosch, Air Liquide, TotalEnergies, TEAL Mobility, MB Energy

September 3, 2026

Journalists wanting further information, please contact:
Claes Eliasson, Head of Media Relations
+46 76 553 7229
press@volvo.com

For more information, please visit volvogroup.com
For frequent updates, follow us on LinkedIn

The Volvo Group drives prosperity through transport and infrastructure solutions, offering trucks, buses, construction equipment, power solutions for marine and industrial applications, financing and services that increase our customers’ uptime and productivity. Founded in 1927, the Volvo Group is committed to shaping the future landscape of sustainable transport and infrastructure solutions. The Volvo Group is headquartered in Gothenburg, Sweden, employs almost 100,000 people and serves customers in almost 180 markets. In 2025, net sales amounted to SEK 479 billion (EUR 43 billion). Volvo shares are listed on Nasdaq Stockholm.

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/ab-volvo/r/industry-leaders-to-join-forces-to-scale-hydrogen-mobility,c4391363

The following files are available for download:

https://mb.cision.com/Main/39/4391363/4249230.pdf

Press release â€” Industry leaders to join forces to scale hydrogen mobility

https://news.cision.com/ab-volvo/i/1860×1050-iaa-pr,c3561719

1860×1050 IAA PR

View original content:https://www.prnewswire.com/news-releases/industry-leaders-to-join-forces-to-scale-hydrogen-mobility-302868716.html

SOURCE AB Volvo

Technology

CFD Broker Mitrade EU Introduces Excess-of-Loss Insurance Protection for Its Clients

Published

20 minutes ago

September 3, 2026

LIMASSOL, Cyprus, Sept. 3, 2026 /PRNewswire/ — CFD broker Mitrade has arranged additional insolvency insurance for eligible clients onboarded under its CySEC licence. The initiative reflects a broader focus on strengthening client confidence and investor protection.

This excess-of-loss policy supplements protections CySEC already mandates. CySEC-authorised investment firms are required to segregate client funds and contribute to the Investor Compensation Fund. Beyond those statutory safeguards, Mitrade EU Limited’s discretionary insurance coverage has been arranged through Lloyd’s of London and funded by Mitrade. It is automatically available to eligible clients without an opt-in requirement or additional client charge.

Should Mitrade EU Limited become insolvent, the policy may cover eligible claims, subject to its terms, conditions and exclusions, up to a maximum aggregate amount of €1 million across all claims combined. It does not cover trading losses or losses caused by market movements.

“Regulation sets the baseline; we decide how much further to go for clients,” said Timur Konsky, CEO of Mitrade EU. “That is why we put additional insurance in place with Lloyd’s of London. Our approach is to identify where clients can be protected and take steps to reduce those risks. Transparency and safety should not be marketing language; they should be demonstrated through the safeguards a broker chooses to put in place. We want our clients to judge us by our actions, and this policy is another concrete example of that commitment.”

Mitrade EU’s excess-of-loss insurance cover takes effect from 1 September 2026.

About Mitrade

Mitrade is a CFD trading platform operating in eligible EEA markets through Mitrade EU Limited, a CySEC-authorised investment firm (CIF438/23). Other legally separate entities within the international group are independently authorised and regulated in their respective jurisdictions by ASIC (AFSL398528), CIMA (SIB1612446), FSCA (FSP54842), FSC (GB20025791), and CMA (20200000397).

Globally, the brand connects 7M+ traders to 1,000+ CFDs on indices, forex, commodities, shares, ETFs and more. The platform is designed to provide fast execution, flexible leverage on a per-position basis, competitive spreads and an intuitive interface accessible across multiple devices.

Risk Warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Visit https://www.mitrade.eu for more information.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cfd-broker-mitrade-eu-introduces-excess-of-loss-insurance-protection-for-its-clients-302867016.html

Technology

Aurra Markets Receives ‘Most Transparent Broker’ Award in Mumbai

Published

20 minutes ago

September 3, 2026

Aurra Markets wins the ‘Most Transparent Broker’ award at Money Expo Mumbai 2026. Read about our MT5 infrastructure and Aurra Wallet.

MUMBAI, India, Sept. 3, 2026 /PRNewswire/ — Aurra Markets Wins ‘Most Transparent Broker’ Award at Money Expo Mumbai

Aurra Markets, a multi-asset CFD broker, received the ‘Most Transparent Broker’ award at Money Expo Mumbai 2026. Participating as a Diamond Sponsor at the Jio World Convention Centre, the brokerage presented its institutional-grade trading infrastructure and partnership models to the Indian financial community.

Direct Market Access and Tier-1 Liquidity

Receiving this award reflects the company’s focus on maintaining secure trading conditions. In active financial markets, reliability is a primary requirement for retail and institutional traders. By integrating direct Tier-1 liquidity and holding fully segregated client funds, Aurra Markets provides a stable environment for trading forex, precious metals, and indices. The team demonstrated its MetaTrader 5 (MT5) framework at Booth 33, highlighting the 12ms execution speed that supports algorithmic and day traders.

Efficient Funding via the Aurra Wallet

The exhibition also served as a platform to detail the company’s advanced funding infrastructure. Clients can manage their capital using the Aurra Wallet. This unified system bridges fiat and digital assets, allowing traders to handle deposits and withdrawals efficiently. Integrating this technology reduces banking delays and provides rapid market access.

Expanding Operations in the Indian Market

“We are honored to receive the Most Transparent Broker award in Mumbai,” a senior spokesperson for Aurra Markets stated. “This recognition validates our infrastructural investments designed to lower trading costs and maintain security. Engaging with affiliates and traders in India confirms the demand for high-performance trading solutions. We provide market participants with the stability needed to trade macroeconomic shifts.”

About Aurra Markets

Aurra Global Markets Limited is authorized and regulated by the Mauritius Financial Services Commission (FSC) under License No. GB25204837. Aurra Markets provides a global community of traders with the direct infrastructure and technical resources needed to operate in dynamic financial markets. For more information, visit www.aurra.markets.

View original content to download multimedia:https://www.prnewswire.com/news-releases/aurra-markets-receives-most-transparent-broker-award-in-mumbai-302868741.html

SOURCE AURRA GLOBAL MARKETS LIMITED